Skip to main content

Table 1 Demographic and clinical characteristics

From: Augmented efficacy of intermittent theta burst stimulation on the virtual reality-based cycling training for upper limb function in patients with stroke: a double-blinded, randomized controlled trial

  sham iTBS + VCT iTBS + VCT p-value
Age 48.95 ± 9.63 54.36 ± 10.56 0.316a
Gender    0.317b
 Male 10 (90.9%) 8 (66.7%)  
 Female 1 (9.1%) 4 (33.3%)  
Onset time (month) 7.99 ± 5.41 5.01 ± 4.39 0.449a
Stroke type    0.193b
 Infarction 2 (18.2%) 6 (50.0%)  
 Hemorrhage 9 (81.8%) 6 (50.0%)  
Stroke side    1.000b
 Right 4 (36.4%) 5 (41.7%)  
 Left 7 (63.6%) 7 (58.3%)  
Stroke location    1.000b
 Cortical 2 (18.2%) 3 (25.0%)  
 M1 involvement 2 (18.2%) 2 (16.7%)  
 Subcortical 9 (81.8%) 9 (75.0%)  
MEP    0.879b
 Positive 7 (63.6%) 8 (66.7%)  
 Negative 4 (36.4%) 4 (33.3%)  
Aphasia    0.640b
 Yes 3 (27.3%) 2 (16.7%)  
 No 8 (72.7%) 10 (83.3%)  
NIHSS 13.55 ± 2.38 11.92 ± 1.73 0.190a
  1. Data are presented as mean ± standard deviation or number (%)
  2. iTBS intermittent theta burst stimulation, MCA middle cerebral artery, MEP motor evoked potential, NIHSS National Institutes of Health Stroke Scale
  3. aMann-Whitney U tests
  4. bChi-square tests